This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Should You Buy CVS Stock Ahead of Q3 Earnings?
by Benjamin Rains
Let's see if investors should think about buying CVS stock ahead of its Q3 financial results.
Dow Recovers More Than 900 Points in 3 Days: 5 Top Picks
by Nalak Das
The meltdown of the 30-stock Dow was transitory in nature and can provide a good entry point for investors.
Walgreens Boots Alliance (WBA) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed the most recent trading day at $79.90, moving +0.16% from the previous trading session.
Walgreens Boots Alliance (WBA) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Walgreens Boots Alliance (WBA) closed at $76.23 in the latest trading session, marking a +0.65% move from the prior day.
Is Walgreens Boots Alliance (WBA) Outperforming Other Retail-Wholesale Stocks This Year?
by Zacks Equity Research
Is (WBA) Outperforming Other Retail-Wholesale Stocks This Year?
Walgreens Boots Alliance (WBA) Stock Moves -0.48%: What You Should Know
by Zacks Equity Research
In the latest trading session, Walgreens Boots Alliance (WBA) closed at $76.61, marking a -0.48% move from the previous day.
Walgreens Boots (WBA) Stock Looks Like A Cheap, Solid Buy Right Now
by Benjamin Rains
Shares of Walgreens Boots Alliance (WBA) jumped roughly 1.6% Monday as investors continue to dive in after it posted impressive fiscal fourth-quarter results late last week. Looking ahead, the pharmaceutical giant looks poised for strong growth and WBA stock seems like it might be worth buying right now.
Company News For Oct 12, 2018
by Zacks Equity Research
Companies in the news are: DAL, WBA, COST and CRSP
Dow 30 Stock Roundup: Walgreens' Earnings Top, UTX Board OKs Dividend Hike
by Swarup Gupta
The index suffered a particularly dismal week, weighed down by surging bond yields.
Walgreens (WBA) Q4 Earnings Top Estimates, Revenues Lag
by Zacks Equity Research
Walgreens' (WBA) Retail Pharmacy USA division witnesses comparable prescription growth and benefits from a strong retail prescription market.
Walgreens Boots Alliance (WBA) Q4 Earnings Surpass Estimates
by Zacks Equity Research
Walgreens (WBA) delivered earnings and revenue surprises of 2.78% and -0.59%, respectively, for the quarter ended August 2018. Do the numbers hold clues to what lies ahead for the stock?
Walgreens (WBA) Stock Sinks 1.7% Ahead of Q4 Earnings: What to Watch
by Benjamin Rains
Shares of Walgreens Boots Alliance (WBA) slipped 1.7% during regular trading hours Wednesday in a sign that investors might be a tad bit nervous about the pharmacy and cosmetic giant's Q4 earnings results Thursday.
Stock Market News For Oct 9, 2018
by Zacks Equity Research
Stocks ended mostly lower on Monday as fears of rising interest rates continued to dent investor sentiment
Should You Buy Walgreens Boots Alliance (WBA) Ahead of Earnings?
by Zacks Equity Research
Walgreens Boots Alliance (WBA) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
5 Earnings Charts to Kick off Earnings Season
by Tracey Ryniec
Be sure to keep an eye on these bellwether companies this week for clues about the third quarter earnings season.
JPMorgan, Citigroup, Delta Air, Walgreens Boots and Fastenal are part of Zacks Earnings Preview
by Zacks Equity Research
JPMorgan, Citigroup, Delta Air, Walgreens Boots and Fastenal are part of Zacks Earnings Preview
Upcoming Earnings to Watch: WBA, DAL, JPM
by Ryan McQueeney
The traditional report season will really kick off next Friday with usual pack of big banks issuing their latest results. Before then, a few other major companies will report. Make sure to check out these companies as they announce earnings during the week of October 8!
What is Keeping Bank Stocks Down?
by Sheraz Mian
Bank stocks are down -0.8% this year, underperforming the broader market's +8.5% gain, but modestly better than the Finance sector's -3% decline.
Should You Buy Walgreens Boots (WBA) Stock Ahead of Q4 Earnings?
by Benjamin Rains
Walgreens Boots Alliance (WBA) shares have surged 17% in the last three months to outpace the S&P 500's roughly 7% climb as fears that Amazon's (AMZN) pharmaceutical push would doom the pharmacy giant prove overblown. Now the question is should investors consider buying WBA stock ahead of its Q4 earnings release on October 11?
Will Walgreens (WBA) Q4 Earnings Gain From Overall Strength?
by Zacks Equity Research
Several planned developments, early benefits of new pharmacy contracts as well as an increase in volume are consistently driving growth within Walgreens Boots' (WBA) Retail Pharmacy USA division.
Walgreens Boots Alliance (WBA) Q4 Earnings Preview: What to Look Out For
by Zacks Equity Research
Walgreens (WBA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kroger-Walgreens Tie Up, Enables Grocery Delivery at Pharmacy
by Zacks Equity Research
Kroger (KR) also informed that customers visiting the drug retailer's stores can also shop from its popular 'Our Brands' grocery range.
Costco (COST) Q4 Earnings: Solid Comps Run a Key Factor
by Zacks Equity Research
Costco (COST) continues to be one of the dominant retail wholesalers based on the breadth and quality of merchandise offered.
Moving Average Crossover Alert: Walgreens Boots Alliance (WBA)
by Zacks Equity Research
Walgreens Boots Alliance, Inc. (WBA) is looking like an interesting pick from a technical perspective
Stock Market News For Sep 28, 2018
by Zacks Equity Research
Wall Street ended on a positive note on Thursday as a series of robust U.S. economic reports lifted investor confidence.